Atlas Trials

Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)

Clinical trial NCT02849145 · COMPLETED

Trial details

NCT number
NCT02849145
Sponsor
Institut Curie
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Uveal Melanoma
Start date
2014-09-01
Primary completion
2020-02-25
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.